A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity

Osman, A.Mukherjee, S.Loffler, K.Altree, T.Proctor, S.Adams, R.Nguyen, P.O'Reilly, C.Naik, G.Fauska, J.Yao, B.Toson, B.Cai, A.Buhl, D.Naylor, M.Olsson, T.Meyer, S.Rosen, L.Eckert, D.2025-10-282025-10-282024Abstracts of the 17th World Sleep Congress, as published in Sleep Medicine, 2024, vol.115, iss.Suppl. 1, pp.326-3261389-94571878-5506https://hdl.handle.net/2440/148020en© 2023 Published by Elsevier B.V.A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severityConference item10.1016/j.sleep.2023.11.879734389Altree, T. [0000-0003-1979-8975]